Massive study tracks how lockdowns shaped mental health across america

NCT ID NCT05548803

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study invites thousands of adults across the U.S. to share their health records and complete monthly surveys about anxiety, stress, and access to COVID-19 resources. Researchers aim to understand how shelter-in-place policies and containment strategies impacted people's well-being, especially in vulnerable populations. By linking survey answers with real health data, the project hopes to inform better public health decisions during future outbreaks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could reveal which pandemic policies best protect mental health and guide future public health responses.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to everyone, and participation relies on self-reported data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

52,351 people

The number who actually took part.

Started

Mar 2020

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Our goal will be to recruit a large sample of participants that is representative of the US population. In particular, we wish to make inferences about Hispanic/LatinX and African- American/Black subsets of the US population, who appear to be especially vulnerable to both direct (infection-related) and indirect impact of the Pandemic.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥ 18 years 2. Has the capacity to read and comprehend English 3. Has internet access and a device (computer, tablet, laptop, etc.) that can access it Exclusion Criteria: 1\. Unable or unwilling to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advocate Aurora Health

    Downers Grove, Illinois, 60515, United States

  • Albert Einstein College of Medicine

    The Bronx, New York, 10467, United States

  • Baylor Scott and White Health

    Dallas, Texas, 95246, United States

  • NYC Health + Hospitals

    New York, New York, 10004, United States

  • New York University

    New York, New York, 10016, United States

  • Ochsner Health System

    New Orleans, Louisiana, 70121, United States

  • Sutter Health

    Sacramento, California, 95833, United States

  • University of California, San Francisco

    San Francisco, California, 94158, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.